{"id":2946,"date":"2012-07-04T07:31:54","date_gmt":"2012-07-04T04:31:54","guid":{"rendered":"http:\/\/www.ced.org.tr\/?p=2946"},"modified":"2012-07-04T07:31:54","modified_gmt":"2012-07-04T04:31:54","slug":"glaxosmithkline-3-milyar-dolar-tazminat-odeyecek","status":"publish","type":"post","link":"http:\/\/www.ced.org.tr\/?p=2946","title":{"rendered":"GlaxoSmithKline 3 milyar dolar tazminat \u00f6deyecek"},"content":{"rendered":"<p><strong>\u0130la\u00e7 imalat\u00e7\u0131s\u0131 GlaxoSmithKline, Paxil, Wellbutrin ve Avandia ila\u00e7lar\u0131 hakk\u0131nda hatal\u0131 bilgi vererek sa\u011fl\u0131k sistemini doland\u0131rd\u0131\u011f\u0131 gerek\u00e7esiyle 3 milyar dolarl\u0131k rekor tazminat \u00f6deyecek<\/strong><\/p>\n<p>\u00a0<\/p>\n<p><p>\u015eirket, ciddi yan etkilerine ra\u011fmen doktarlar\u0131n bu ila\u00e7lar\u0131 re\u00e7etelerine yazmas\u0131 i\u00e7in r\u00fc\u015fvete ba\u015fvurmaktan su\u00e7lu bulundu.<\/p>\n<p>D\u00fcnyan\u0131n en b\u00fcy\u00fck ila\u00e7 \u015firketlerinden GlaxoSmithKline, hakk\u0131nda devam eden yolsuzluk davas\u0131nda 3 milyar dolar bedel \u00f6deyerek uzla\u015fma sa\u011flamay\u0131 kabul etti.<\/p>\n<p>\u015eirket; Paxil, Wellbutrin ve Avandia isimli ila\u00e7lar\u0131 t\u0131bbi g\u00fcvenli\u011fi konusunda ilgili makamlara yeterli bilgilendirme yapmadan piyasaya sunmakla su\u00e7lan\u0131yordu.<\/p>\n<p>Soru\u015fturmay\u0131 y\u00fcr\u00fcten savc\u0131 vekili Stuart Delery, yapt\u0131\u011f\u0131 a\u00e7\u0131klamada, insan hayat\u0131yla oynayan bir anlay\u0131\u015fa tolerans g\u00f6stermenin s\u00f6z konusu olamayaca\u011f\u0131n\u0131 kaydetti:<\/p>\n<p>\u201cSa\u011fl\u0131k sisteminde doland\u0131r\u0131c\u0131l\u0131k, hayat\u0131m\u0131za her y\u00f6nden dokunan bir salg\u0131n. Ve dahas\u0131, ila\u00e7 end\u00fcstrisinin bunlar\u0131 sadece ticaret hayat\u0131n\u0131n ola\u011fan bir par\u00e7as\u0131 olarak g\u00f6rd\u00fc\u011f\u00fcn\u00fc duyuyoruz. \u0130\u015fte bu y\u00fczden yarg\u0131, m\u00fcmk\u00fcn olan her yolla sa\u011fl\u0131kta doland\u0131r\u0131c\u0131l\u0131\u011fa meydan vermemek i\u00e7in m\u00fccadeleye kararl\u0131.\u201d<\/p>\n<p>\u00d6te yandan \u015firket, ciddi yan etkilerine ra\u011fmen doktarlar\u0131n bu ila\u00e7lar\u0131 re\u00e7etelerine yazmas\u0131 i\u00e7in r\u00fc\u015fvete ba\u015fvurmaktan su\u00e7lu bulundu.<\/p>\n<p>\u00a0<\/p>\n<p><strong>Uzman yorumlar\u0131, insan hayat\u0131n\u0131n nas\u0131l hi\u00e7e say\u0131ld\u0131\u011f\u0131n\u0131 ortaya koyuyor: <\/strong><\/p>\n<p>\u201cAvandia kullan\u0131m\u0131yla ilintili olarak 50 bin ile 100 bin aras\u0131nda diabet hastas\u0131nda, beklenmedik, istenmeyen kalp krizi vakas\u0131na rastland\u0131. Bu ila\u00e7 \u00e7ok fazla insan\u0131n can\u0131n\u0131 yakt\u0131.\u201d<\/p>\n<p>Euronews&#8217;\u0131n haberine g\u00f6re; Amerika Birle\u015fik Devletleri \u2019nde \u015fimdiye kadarki en b\u00fcy\u00fck sa\u011fl\u0131k yolsuzlu\u011fu davas\u0131nda GlaxoSmithKline\u2019\u0131n \u00f6demeyi kabul etti\u011fi bedelin 1 milyar dolar\u0131n\u0131n su\u00e7 cezas\u0131, kalan k\u0131sm\u0131n\u0131n ise sivil ceza kapsam\u0131nda oldu\u011fu bildirildi.<\/p>\n<p>\u00a0<\/p>\n<p>Radikal<\/p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u0130la\u00e7 imalat\u00e7\u0131s\u0131 GlaxoSmithKline, Paxil, Wellbutrin ve Avandia ila\u00e7lar\u0131 hakk\u0131nda hatal\u0131 bilgi vererek sa\u011fl\u0131k sistemini doland\u0131rd\u0131\u011f\u0131 gerek\u00e7esiyle 3 milyar dolarl\u0131k rekor&#46;&#46;&#46;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[62],"tags":[],"class_list":["post-2946","post","type-post","status-publish","format-standard","hentry","category-sagliktan-haberler"],"aioseo_notices":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack-related-posts":[],"_links":{"self":[{"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=\/wp\/v2\/posts\/2946","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2946"}],"version-history":[{"count":0,"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=\/wp\/v2\/posts\/2946\/revisions"}],"wp:attachment":[{"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2946"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2946"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2946"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}